AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Sep 1, 2005
35134_dirs_2005-08-31_cd79186b-234b-4051-8b47-34e29a0276fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-08-31
Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-08-28 | Croff Enterprises Inc Class B Preferred Shares | P | 75050 | $3 | Acquired | 328241 | Direct |
Footnotes
F1: Not all of these shares have been delivered. This number represents the total number of shares tendered and not withdrawn as part of the Tender Offer for the Class B Preferred Shares.
F2: This includes 132130 shares held by Jensen Development Comapny which is wholly owned by Gerald L. Jensen. This number also includes the 75,050 shares tendered in the Tender Offer for the Class B Preferred B shares, some of which are not yet delivered.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16